Jiani Guo

Jiani Guo

Auto-generated profile, based on publicly available information

Jiani Guo

Department of Medical Oncology, The Affiliated Huaian No. 1 People’s Hospital of Nanjing Medical University, Huai’an, Jiangsu, China

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2016 in OncoTargets and Therapy
Verified
Journal Article
Open access
PDF file
JGJia-Ni Guo
Jia-Ni Guo
JLJin Li
Jin Li
CZChang-Li Zhu
Chang-Li Zhu
WFWan-Ting Feng
Wan-Ting Feng
JSJing-Xian Shao
Jing-Xian Shao
JHJingdong He
Jingdong He
Background: Nowadays, despite great progress in cancer research, the detailed mechanisms of colorectal cancer (CRC) are still poorly understood. Circular RNAs (circRNAs), a new star of the non-coding RNA network, have been identified as critical regulators in various cancers, including CRC. Methods and results: In this study, by using unsupervised hierarchical clustering analysis, a novel dysregulated circRNA, hsa_circ_0000069, was found. The expression of hsa_circ_0000069 was measured in 30 paired CRC tissues and adjacent noncancerous tissues using quantitative polymerase chain reaction. A high expression of hsa_circ_0000069 was observed in CRC tissues and correlated with patients’ age and tumor, node, metastasis (TNM) stage (P<0.05). Furthermore, by using specifically designed siRNAs in CRC cells, a functional analysis was performed which revealed that hsa_circ_0000069 knockdown could notably inhibit cell proliferation, migration, and invasion, and induce G0/G1 phase arrest of cell cycle in vitro. Conclusion: This study’s findings are the first to demonstrate that hsa_circ_0000069, an important regulator in cancer progression, could be a promising target in the diagnosis and therapy in colorectal cancer.

30 August 2016 in Cancer Medicine
Verified
Journal Article
Open access
PDF file
HLHong‐Lei Luo
Hong‐Lei Luo
MHMing‐De Huang
Ming‐De Huang
JGJia‐Ni Guo
Jia‐Ni Guo
RFRui‐Hua Fan
Rui‐Hua Fan
XXXiao‐Tian Xia
Xiao‐Tian Xia
XCXiao‐Fei Chen
Xiao‐Fei Chen
Recent findings indicate that long noncoding RNAs (lncRNAs) were dysregulated in many kinds of tumors including esophageal squamous cell carcinoma (ESCC). LncRNA AFAP1‐AS1 was found to be upregulated in hepatocellular carcinoma (HCC), lung cancer, colorectal cancer, esophageal adenocarcinoma (EAC), pancreatic ductal adenocarcinoma, and nasopharyngeal carcinoma, while its clinical value and potential function in ESCC are still unknown. Expression of AFAP1‐AS1 was measured in 65 ESCC tissues and corresponding noncancerous tissues by quantitative real‐time polymerase chain reaction, which revealed that AFAP1‐AS1 expression was markedly elevated in ESCC tissues and significantly associated with advanced TNM stage (P = 0.004) and larger tumor size (P = 0.040). Moreover, by knocking down AFAP1‐AS1 expression in ESCC cells, the proliferation and colony‐forming ability were inhibited and cell apoptosis was induced. Our data indicated the first time that AFAP1‐AS1, a novel oncogene, was remarkably upregulated and played a critical role in the progression of ESCC.

26 October 2021 in Cancer Medicine
Verified
Journal Article
Open access
PDF file
YHYadi Huang
Yadi Huang
LJLinlin Ji
Linlin Ji
JZJialong Zhu
Jialong Zhu
XMXiaobei Mao
Xiaobei Mao
SSSiqi Sheng
Siqi Sheng
XCXiaoyuan Chu
Xiaoyuan Chu
Background: Some significant differences exist between the outcomes of left‐ and right‐sided colon cancer patients. The presence of nodal metastases is a critical prognostic factor, especially in the absence of distant metastasis. Our research studied the lymph nodes status of left‐ and right‐sided colon cancer patients to determine the influence of this factor on prognosis.Methods: Our data were obtained from the Surveillance, Epidemiology and End Results (SEER) database. We used the chi‐square test to analyze the clinicopathological characteristics. The X‐tile program was adopted to acquire optimal cutoff points of lymph node index. Kaplan–Meier curves were used to analyze prognosis and multivariate Cox regression models were performed to identify the independent factors associated with survival. Nomograms were built to predict the overall survival of patients, Harrell's C‐index and calibration plots were used to validate the nomograms.Results: The study included 189,941 patients with colon cancer without metastasis (left 69,885, right 120,056) between 2004 and 2015. There are more patients with adequate examined lymph nodes in right‐sided. Lymph node status in patients with right colon cancer has a more significant impact on the risk of death. LODDS (C‐index: 0.583; AIC: 6875.4) was used to assess lymph node status. The nomograms showed that lymph node status was the main factor to predict the outcome in right‐sided colon patients.Conclusions: The influence of lymph node status on predicting prognosis is significantly different between patients with left and right colon cancer without metastasis. The tumor site needs to be considered when lymph node status is used to assess the outcome of patients.

27 November 2021 in Journal of Oncology
Verified
Journal Article
Open access
PDF file
JGJiani Guo
Jiani Guo
XYXuesong Yi
Xuesong Yi
ZJZhuqing Ji
Zhuqing Ji
MYMengchu Yao
Mengchu Yao
YYYu Yang
Yu Yang
MHMingde Huang
Mingde Huang
Background. Triple-negative breast cancer (TNBC) remains the most incurable subtype of breast cancer owing to high heterogeneity, aggressive nature, and lack of treatment options. It is generally acknowledged that epithelial-mesenchymal transition (EMT) is the key step in tumor metastasis. Methods. With the application of TCGA and GEO databases, we identified EMT-related lncRNAs by the Cox univariate regression analysis. Optimum risk scores were calculated and used to divide TNBC patients into high-/low-risk subgroups by the median value using the Lasso regression analysis. The KaplanMeier and ROC curve analyses were applied for model validation. Then, we assessed the risk model from multi-omic aspects including immune infiltration, drug sensitivity, mutability spectrum, signaling pathways, and clinical indicators. We also analyzed the expression pattern of lncRNAs involved in the model using qRT-PCR in TNBC cell lines and constructed the ceRNA network. Results. The risk model was composed of EMT-related long noncoding RNAs (lncRNAs), which seemed to be valuable in the prognostic prediction of TNBC patients. The model could act as an independent prognostic factor of TNBC and showed a robust prognostic ability in the stratification analysis. Further investigation demonstrated that the expression of lncRNAs was different between high aggressive and low aggressive TNBC cell lines, as well as TNBC patients. Conclusions. Together, our study successfully established a risk model with great accuracy and efficacy in the prognostic prediction of TNBC patients.

31 March 2021 in Research Square
Verified
Preprint
Open access
PDF file
JGJiani Guo
Jiani Guo
XYXuesong Yi
Xuesong Yi
ZJZhuqing Ji
Zhuqing Ji
MYMengchu Yao
Mengchu Yao
YYYu Yang
Yu Yang
MHMingde Huang
Mingde Huang
Background: Triple negative breast cancer (TNBC) remains the most incurable subtype of breast cancer owing to high heterogeneity, aggressive nature, and lack of treatment options. It is generally acknowledged that epithelial-mesenchymal transition (EMT) is the key step in tumor metastasis. Methods: With the application of TCGA and GEO database, we identified EMT-related lncRNAs by Cox univariate regression analysis. Optimum risk scores were calculated and used to divide TNBC patients into high/low-risk subgroups by the median value using lasso regression analysis. Kaplan-Meier and ROC curve analyses were applied for model validation. Then we assessed the risk model from multi-omic aspects including immune infiltration, drug sensitivity, mutability spectrum, signaling pathways, and clinical indicators.Results: The risk model was composed of 22 EMT-related long noncoding RNAs (lncRNAs), which seemed to be valuable in prognostic prediction of TNBC patients. The model could act as an independent prognostic factor of TNBC, and showed a robust prognostic ability in the stratification analysis. Conclusions: Together, our study successfully established a risk model with great accuracy and efficacy in prognosis prediction of TNBC patients.

18 November 2026 in Advanced Science
Verified
Journal Article
Open access
LNLike Ning
Like Ning
YSYuting Shao
Yuting Shao
CYChaoqun You
Chaoqun You
YQYingxuan Qian
Yingxuan Qian
HYHanyang Yu
Hanyang Yu
FLFan Lin
Fan Lin
Tumor recurrence remains the predominant cause of mortality in patients with glioblastoma (GBM), and (chemo/radio‐) therapy‐induced senescence (TIS) has recently been recognized as a key driver by deteriorating the post‐surgical microenvironment. To exploit this “senescence trap”, we developed an injectable, bacterial cellulose (BC)‐based hydrogel system (ABT@Gal‐gel) designed for preferential elimination of senescent GBM cells. This platform encapsulates galactose‐modified polydopamine nanoparticles loaded with the senolytic agent ABT‐263 (ABT@Gal‐PDA). It enables programmed, β‐galactosidase (β‐Gal)‐responsive drug release to preferentially eliminate pro‐tumorigenic senescent cells. Moreover, the cellulose and chitosan in the hydrogel further remodel the immunosuppressive tumor microenvironment by inducing M1 macrophage polarization. In orthotopic GBM mouse models, this dual‐functional strategy significantly inhibits tumor recurrence and prolongs overall survival. Overall, this study presents a novel strategy by coupling senescence‐associated intracellular targeting with tumor‐associated macrophage (TAM) repolarization to suppress GBM relapses, providing a promising direction for the next generation of postoperative brain cancer therapies.